Evidence Hub

Comparative Efficacy and Safety of Antibacterial Regimens for Severe Stenotrophomonas maltophilia Infections: A Systematic Review and Network Meta-Analysis

Suyu Gao, Yun Lu, Qi Qiao

International Journal of Infectious Diseases, 2026

Abstract

BACKGROUND

Stenotrophomonas maltophilia (SMA) is a multidrug-resistant pathogen with high mortality. Trimethoprim-sulfamethoxazole (TMP-SMX), the conventional preferred therapy, is limited by toxicity and resistance.

METHODS

We searched PubMed, Embase, Cochrane, and Web of Science up to April 2026 for cohorts comparing TMP-SMX, levofloxacin, minocycline, and tigecycline. A frequentist random-effects network meta-analysis was performed. Primary outcomes were overall survival and clinical efficacy (odds ratios [ORs] with 95% CIs). Treatments were ranked by SUCRA.

RESULTS

Fifteen cohorts were included. Levofloxacin significantly improved survival versus TMP-SMX (OR=2.01, 95%CI 1.16-3.47, P=0.012). Tigecycline showed the highest clinical response (OR=4.97, 95%CI 1.69-14.61, P=0.004) but no survival benefit. SUCRA ranked levofloxacin first for mortality reduction (91.3%) and tigecycline first for efficacy (91.3%); minocycline performed consistently across endpoints.

CONCLUSIONS

A "survival paradox" exists in SMA treatment: tigecycline yields superior initial response without improving survival, whereas levofloxacin provides the most significant survival benefit. Levofloxacin should be prioritized for critically ill patients, while high-dose TMP-SMX and tigecycline warrant cautious re-evaluation.

How strong is the evidence?

Evidence Hub reads this as a meta-analysis, done in people. Its evidence level is 1 of 5 (Highest · pooled evidence). Pooled evidence from several studies sits at the top of the evidence pyramid.

How the five levels of evidence work. The level is assigned automatically from the abstract and can be wrong, so check the paper.

Read the paper

Related studies

Go deeper in Evidence Hub

Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.

Open this study Sign up free